Assessing Mood With the Identifying Depression Early in Adolescence Chatbot (IDEABot): Development and Implementation Study.

adolescent ambulatory assessment chatbot depression digital mental health mobile phone smartphone

Journal

JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561

Informations de publication

Date de publication:
07 Aug 2023
Historique:
received: 24 11 2022
accepted: 02 05 2023
revised: 03 04 2023
medline: 7 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

Mental health status assessment is mostly limited to clinical or research settings, but recent technological advances provide new opportunities for measurement using more ecological approaches. Leveraging apps already in use by individuals on their smartphones, such as chatbots, could be a useful approach to capture subjective reports of mood in the moment. This study aimed to describe the development and implementation of the Identifying Depression Early in Adolescence Chatbot (IDEABot), a WhatsApp-based tool designed for collecting intensive longitudinal data on adolescents' mood. The IDEABot was developed to collect data from Brazilian adolescents via WhatsApp as part of the Identifying Depression Early in Adolescence Risk Stratified Cohort (IDEA-RiSCo) study. It supports the administration and collection of self-reported structured items or questionnaires and audio responses. The development explored WhatsApp's default features, such as emojis and recorded audio messages, and focused on scripting relevant and acceptable conversations. The IDEABot supports 5 types of interactions: textual and audio questions, administration of a version of the Short Mood and Feelings Questionnaire, unprompted interactions, and a snooze function. Six adolescents (n=4, 67% male participants and n=2, 33% female participants) aged 16 to 18 years tested the initial version of the IDEABot and were engaged to codevelop the final version of the app. The IDEABot was subsequently used for data collection in the second- and third-year follow-ups of the IDEA-RiSCo study. The adolescents assessed the initial version of the IDEABot as enjoyable and made suggestions for improvements that were subsequently implemented. The IDEABot's final version follows a structured script with the choice of answer based on exact text matches throughout 15 days. The implementation of the IDEABot in 2 waves of the IDEA-RiSCo sample (140 and 132 eligible adolescents in the second- and third-year follow-ups, respectively) evidenced adequate engagement indicators, with good acceptance for using the tool (113/140, 80.7% and 122/132, 92.4% for second- and third-year follow-up use, respectively), low attrition (only 1/113, 0.9% and 1/122, 0.8%, respectively, failed to engage in the protocol after initial interaction), and high compliance in terms of the proportion of responses in relation to the total number of elicited prompts (12.8, SD 3.5; 91% out of 14 possible interactions and 10.57, SD 3.4; 76% out of 14 possible interactions, respectively). The IDEABot is a frugal app that leverages an existing app already in daily use by our target population. It follows a simple rule-based approach that can be easily tested and implemented in diverse settings and possibly diminishes the burden of intensive data collection for participants by repurposing WhatsApp. In this context, the IDEABot appears as an acceptable and potentially scalable tool for gathering momentary information that can enhance our understanding of mood fluctuations and development.

Sections du résumé

BACKGROUND BACKGROUND
Mental health status assessment is mostly limited to clinical or research settings, but recent technological advances provide new opportunities for measurement using more ecological approaches. Leveraging apps already in use by individuals on their smartphones, such as chatbots, could be a useful approach to capture subjective reports of mood in the moment.
OBJECTIVE OBJECTIVE
This study aimed to describe the development and implementation of the Identifying Depression Early in Adolescence Chatbot (IDEABot), a WhatsApp-based tool designed for collecting intensive longitudinal data on adolescents' mood.
METHODS METHODS
The IDEABot was developed to collect data from Brazilian adolescents via WhatsApp as part of the Identifying Depression Early in Adolescence Risk Stratified Cohort (IDEA-RiSCo) study. It supports the administration and collection of self-reported structured items or questionnaires and audio responses. The development explored WhatsApp's default features, such as emojis and recorded audio messages, and focused on scripting relevant and acceptable conversations. The IDEABot supports 5 types of interactions: textual and audio questions, administration of a version of the Short Mood and Feelings Questionnaire, unprompted interactions, and a snooze function. Six adolescents (n=4, 67% male participants and n=2, 33% female participants) aged 16 to 18 years tested the initial version of the IDEABot and were engaged to codevelop the final version of the app. The IDEABot was subsequently used for data collection in the second- and third-year follow-ups of the IDEA-RiSCo study.
RESULTS RESULTS
The adolescents assessed the initial version of the IDEABot as enjoyable and made suggestions for improvements that were subsequently implemented. The IDEABot's final version follows a structured script with the choice of answer based on exact text matches throughout 15 days. The implementation of the IDEABot in 2 waves of the IDEA-RiSCo sample (140 and 132 eligible adolescents in the second- and third-year follow-ups, respectively) evidenced adequate engagement indicators, with good acceptance for using the tool (113/140, 80.7% and 122/132, 92.4% for second- and third-year follow-up use, respectively), low attrition (only 1/113, 0.9% and 1/122, 0.8%, respectively, failed to engage in the protocol after initial interaction), and high compliance in terms of the proportion of responses in relation to the total number of elicited prompts (12.8, SD 3.5; 91% out of 14 possible interactions and 10.57, SD 3.4; 76% out of 14 possible interactions, respectively).
CONCLUSIONS CONCLUSIONS
The IDEABot is a frugal app that leverages an existing app already in daily use by our target population. It follows a simple rule-based approach that can be easily tested and implemented in diverse settings and possibly diminishes the burden of intensive data collection for participants by repurposing WhatsApp. In this context, the IDEABot appears as an acceptable and potentially scalable tool for gathering momentary information that can enhance our understanding of mood fluctuations and development.

Identifiants

pubmed: 37548996
pii: v10i1e44388
doi: 10.2196/44388
pmc: PMC10442728
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e44388

Informations de copyright

©Anna Viduani, Victor Cosenza, Helen L Fisher, Claudia Buchweitz, Jader Piccin, Rivka Pereira, Brandon A Kohrt, Valeria Mondelli, Alastair van Heerden, Ricardo Matsumura Araújo, Christian Kieling. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 07.08.2023.

Références

Psychiatr Serv. 2019 Jul 1;70(7):538-544
pubmed: 30914003
J Med Internet Res. 2020 Aug 7;22(8):e17158
pubmed: 32763886
JMIR Ment Health. 2018 Dec 13;5(4):e64
pubmed: 30545815
J Adolesc Health. 2011 May;48(5):514-9
pubmed: 21501812
Br J Psychiatry. 2022 Jan 07;:1-3
pubmed: 35048814
Lancet Child Adolesc Health. 2019 Apr;3(4):211-213
pubmed: 30878111
J Am Med Inform Assoc. 2018 Sep 1;25(9):1248-1258
pubmed: 30010941
Ann Intern Med. 1983 Dec;99(6):843-8
pubmed: 6651026
Neuroimage. 2021 May 1;231:117865
pubmed: 33592242
Can J Psychiatry. 2019 Jul;64(7):456-464
pubmed: 30897957
Addiction. 2019 Apr;114(4):609-619
pubmed: 30461120
JMIR Hum Factors. 2021 Mar 18;8(1):e24343
pubmed: 33734089
Psychother Psychosom. 2022;91(1):1-7
pubmed: 34839291
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Int J Med Inform. 2019 Dec;132:103978
pubmed: 31622850
Assessment. 2023 Mar 13;:10731911231159937
pubmed: 36914966
JMIR Form Res. 2022 Jan 19;6(1):e28003
pubmed: 35044314
J Psychiatry Neurosci. 2006 Jan;31(1):13-20
pubmed: 16496031
J Consult Clin Psychol. 2020 Jan;88(1):1-13
pubmed: 31697093
JMIR Ment Health. 2016 Mar 01;3(1):e7
pubmed: 26932350
J Am Acad Child Adolesc Psychiatry. 2021 Feb;60(2):262-273
pubmed: 31953186
Lancet. 2011 Oct 22;378(9801):1515-25
pubmed: 22008427
Trends Psychiatry Psychother. 2022 Dec 20;:
pubmed: 36598857
Trends Psychiatry Psychother. 2018 Apr 05;40(1):72-78
pubmed: 29641647
Front Psychiatry. 2021 Jun 21;12:697144
pubmed: 34234702
J Med Internet Res. 2005 Mar 31;7(1):e11
pubmed: 15829473
J Child Psychol Psychiatry. 2020 Mar;61(3):376-394
pubmed: 31997358
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Qual Health Res. 2014 May;24(5):629-40
pubmed: 24667100

Auteurs

Anna Viduani (A)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Child and Adolescent Psychiatry Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Victor Cosenza (V)

Center for Technological Advancement, Universidade Federal de Pelotas, Pelotas, Brazil.

Helen L Fisher (HL)

Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Economic and Social Research Council Centre for Society and Mental Health, King's College London, London, United Kingdom.

Claudia Buchweitz (C)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Child and Adolescent Psychiatry Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Jader Piccin (J)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Child and Adolescent Psychiatry Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Rivka Pereira (R)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Child and Adolescent Psychiatry Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Brandon A Kohrt (BA)

Division of Global Mental Health, Department of Psychiatry, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United States.

Valeria Mondelli (V)

Department of Psychological Medicine, Institute of Psychiatry, Psychology, King's College London, London, United Kingdom.

Alastair van Heerden (A)

Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.

Ricardo Matsumura Araújo (RM)

Center for Technological Advancement, Universidade Federal de Pelotas, Pelotas, Brazil.

Christian Kieling (C)

Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Child and Adolescent Psychiatry Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Classifications MeSH